Apple Health Medicaid: Fee-for-Service Preferred Drug List (PDL)



 


HCA Logo


Apple Health (Medicaid): Provider Alert


Dear Provider,

Retroactive for claims with dates of service on and after June 1, 2017, the Health Care Authority (agency) is correcting an error in the Apple Health (Medicaid): Fee-for- Service Preferred Drug List (PDL):

Drug Class

Drug Name

Change

Diabetes Drugs -- Long-Acting Insulins

Basaglar Kwikpen®

Basaglar Kwikpen® was listed incorrectly as Preferred. The agency has changed it to Non-Preferred and added the drug to the “What is new?” list for June 1. Prior authorization is required.


For more details, see the agency’s Apple Health Medicaid: Fee-for-Service Preferred Drug List.